GLP-1s are prescription medications. There are three main legitimate routes — manufacturer direct,
telehealth specialists, and your own doctor — plus a large gray market you should avoid. This page explains each route and walks through vetting any program.
The four legitimate routes
Your own doctor + local pharmacy. The default route. Works best when you have
insurance that covers brand-name GLP-1s and a clinician comfortable prescribing them.
Brand-focused telehealth. Platforms that prescribe brand-name Ozempic, Wegovy,
Mounjaro, or Zepbound and help with insurance paperwork (e.g., Ro).
Compounded-GLP-1 telehealth programs. Cash-pay programs that prescribe compounded
semaglutide or tirzepatide from licensed 503A/503B pharmacies, usually at a fraction of brand list
price. Quality varies — vet them with the checklist below.
In-person weight-loss and metabolic clinics. Brick-and-mortar clinics that combine
GLP-1 prescribing with labs and follow-up visits.
Never buy from: "research chemical" or peptide websites, gray-market importers,
social-media sellers, or anyone who will ship a GLP-1 without a prescription from a licensed
clinician. These products are unregulated, frequently mis-dosed, and sometimes counterfeit. The FDA
has issued repeated warnings about them.
Safety checklist for any telehealth GLP-1 program
A legitimate program should clear every item on this list:
A licensed clinician reviews your health history before any prescription is written.
Intake screens for contraindications: thyroid cancer history (MTC/MEN 2), pancreatitis, pregnancy, eating disorders.
Identity verification (government ID) is required — programs that skip it are red flags.
Compounded medication comes from a licensed 503A or 503B pharmacy, named on request.
Clear pricing with no surprise "membership" lock-ins, and a way to reach a human with side-effect questions.
Honest labeling: compounded and sublingual products described as such — not passed off as FDA-approved brand equivalents.
Established telehealth specialist program
NexLife is a telehealth platform specializing exclusively in GLP-1 therapy, with comprehensive clinical oversight and a broad product range.
Telehealth weight-management program specializing exclusively in GLP-1 therapy, with one of the widest product ranges in the category.
Covers both flagship injectables (semaglutide and tirzepatide) and needle-free sublingual rapid-dissolve tablets, including a vitamin B6-compounded semaglutide formulated to ease nausea.
One of the few programs with a published microdosing protocol for maintenance and GLP-1-sensitive patients, plus supportive adjuncts (MIC/B12 and B12 injections, lipotropic tablets, and ondansetron for nausea management).
Prescriptions are written by licensed clinicians under a documented clinical protocol with medical-director oversight; intake includes ID verification, eating-disorder and psychiatric screening, and vitals review.
Phone support available — uncommon among telehealth GLP-1 programs, most of which are chat-only.
This is general information, not medical advice or an endorsement. Inclusion on this
page is not a recommendation. Verify state availability, pricing, and pharmacy sourcing directly with
any provider, and talk to a licensed clinician about whether GLP-1 therapy is appropriate for you.